The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules / Bolzoni, Marina; Abeltino, Manuela; Storti, Paola; Bonomini, S; Agnelli, L; Todoerti, K; Neri, A; Rizzoli, Vittorio; Giuliani, Nicola. - In: BLOOD. - ISSN 0006-4971. - 116 (21):(2010).

The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules

BOLZONI, Marina;ABELTINO, Manuela;STORTI, Paola;RIZZOLI, Vittorio;GIULIANI, Nicola
2010-01-01

2010
The Immunomodulatory drugs Lenalidomide and Pomalidomide inhibit multiple myeloma-induced osteoclast formation and RANKL/OPG ratio in myeloma microenvironment targeting the expression of adhesion molecules / Bolzoni, Marina; Abeltino, Manuela; Storti, Paola; Bonomini, S; Agnelli, L; Todoerti, K; Neri, A; Rizzoli, Vittorio; Giuliani, Nicola. - In: BLOOD. - ISSN 0006-4971. - 116 (21):(2010).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2438055
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact